Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial
Sign Up to like & getrecommendations! Published in 2018 at "CNS Drugs"
DOI: 10.1007/s40263-018-0516-6
Abstract: BackgroundGamma-hydroxybutyrate (GHB) dependence is associated with a severe, potentially lethal, withdrawal syndrome and relapse rates as high as 60% within 3 months of detoxification. Baclofen has been shown to decrease self-administration of GHB in mice and… read more here.
Keywords: trial; relapse; hydroxybutyrate ghb; dependent patients ... See more keywords
Gamma-Hydroxybutyrate (GHB) Withdrawal in a Patient with Polysubstance Use.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of psychoactive drugs"
DOI: 10.1080/02791072.2020.1865591
Abstract: Gamma-hydroxybutyrate (GHB) and its various pro-drugs are GABA-B central nervous system depressants more commonly known as "G" and "liquid ecstasy" among those who consume. Due to the depressant quality of the substance and its convenience… read more here.
Keywords: polysubstance use; hydroxybutyrate ghb; withdrawal patient; withdrawal ... See more keywords